Siming Xie

626 total citations
24 papers, 519 citations indexed

About

Siming Xie is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Siming Xie has authored 24 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Genetics. Recurrent topics in Siming Xie's work include RNA modifications and cancer (5 papers), Cancer Cells and Metastasis (4 papers) and Glioma Diagnosis and Treatment (3 papers). Siming Xie is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer Cells and Metastasis (4 papers) and Glioma Diagnosis and Treatment (3 papers). Siming Xie collaborates with scholars based in China, United States and Lebanon. Siming Xie's co-authors include Weiyi Fang, Kai‐Tai Yao, Xueyun Zhong, Xin Li, Yong Zhang, Jiwei Ma, Qingping Jiang, Huiling Yang, Zhen Liu and Bin Du and has published in prestigious journals such as Water Research, International Journal of Cancer and Molecular Cancer.

In The Last Decade

Siming Xie

22 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Siming Xie China 11 317 139 118 55 48 24 519
Masashi Hatori Japan 14 345 1.1× 171 1.2× 167 1.4× 48 0.9× 34 0.7× 45 713
Vui King Vincent–Chong Malaysia 15 243 0.8× 117 0.8× 124 1.1× 74 1.3× 21 0.4× 30 484
Hana Lee South Korea 13 262 0.8× 89 0.6× 113 1.0× 99 1.8× 25 0.5× 31 519
Zumin Xu China 13 294 0.9× 109 0.8× 141 1.2× 47 0.9× 37 0.8× 24 427
Justine Bellier Belgium 11 270 0.9× 211 1.5× 159 1.3× 55 1.0× 48 1.0× 11 632
Chie Nakashima Japan 17 348 1.1× 143 1.0× 215 1.8× 81 1.5× 42 0.9× 43 607
Yue‐Can Zeng China 14 192 0.6× 182 1.3× 78 0.7× 62 1.1× 26 0.5× 29 460
Di Xiang China 15 284 0.9× 132 0.9× 101 0.9× 84 1.5× 23 0.5× 27 559
Gayani Pitiyage United Kingdom 10 288 0.9× 165 1.2× 139 1.2× 64 1.2× 40 0.8× 17 842
Renqiang Ma China 15 272 0.9× 115 0.8× 144 1.2× 111 2.0× 17 0.4× 45 605

Countries citing papers authored by Siming Xie

Since Specialization
Citations

This map shows the geographic impact of Siming Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siming Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siming Xie more than expected).

Fields of papers citing papers by Siming Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siming Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siming Xie. The network helps show where Siming Xie may publish in the future.

Co-authorship network of co-authors of Siming Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Siming Xie. A scholar is included among the top collaborators of Siming Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siming Xie. Siming Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Shuili, et al.. (2025). Purifying or polluting? Tracing membrane-based microplastics release for long-term drinking water safety. Water Research. 289(Pt B). 124991–124991.
2.
Xie, Siming, et al.. (2023). Malignant transformation rate of oral leukoplakia in the past 20 years: A systematic review and meta‐analysis. Journal of Oral Pathology and Medicine. 52(8). 691–700. 23 indexed citations
3.
Xie, Siming, et al.. (2022). Decrease of Membrane B7-H5 on CD14+ Cells in Severe Acute Pancreatitis Is Related to RANSON Scores and APACHE II Scores. Digestive Diseases and Sciences. 68(3). 824–830. 1 indexed citations
4.
Pei, Yigang, Siming Xie, Wenzheng Li, et al.. (2020). Evaluation of simultaneous-multislice diffusion-weighted imaging of liver at 3.0 T with different breathing schemes. Abdominal Radiology. 45(11). 3716–3729. 14 indexed citations
5.
Li, Chen, Zhihong Huang, Wenlong Li, et al.. (2016). The Nucleotide-Binding Oligomerization Domain–Like Receptor Family Pyrin Domain-Containing 3 Inflammasome Regulates Bronchial Epithelial Cell Injury and Proapoptosis after Exposure to Biomass Fuel Smoke. American Journal of Respiratory Cell and Molecular Biology. 55(6). 815–824. 34 indexed citations
6.
Lu, Zhiyuan, et al.. (2016). Effects of PTEN gene silencing on invasion and EMT in oral squamous carcinoma Tca8113 cells. Journal of Oral Pathology and Medicine. 46(1). 31–38. 3 indexed citations
7.
Zhang, Qianbing, Shuang Wang, Siming Xie, et al.. (2015). A Fraction of CD133+ CNE2 Cells Is Made of Giant Cancer Cells with Morphological Evidence of Asymmetric Mitosis. Journal of Cancer. 6(12). 1236–1244. 25 indexed citations
9.
Zhang, Yong, Shaoxiang Wang, Jiwei Ma, et al.. (2014). EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition. Journal of Neuro-Oncology. 121(1). 41–52. 83 indexed citations
10.
Zhu, Huili, et al.. (2013). 4E‐BP1 regulates the sensitivity of human glioma cells to chemotherapy through PI3K/Akt/mTOR‐independent pathway. Neuropathology. 34(3). 227–235. 4 indexed citations
11.
Wang, Chao, Fang Mao, Meng Zhang, et al.. (2013). The positive correlation between DJ‐1 and β‐catenin expression shows prognostic value for patients with glioma. Neuropathology. 33(6). 628–636. 12 indexed citations
12.
Xie, Siming, Fang Mao, Hui Guo, & Xueyun Zhong. (2011). Silencing of MGMT with small interference RNA reversed resistance in human BCUN-resistant glioma cell lines.. PubMed. 124(17). 2605–10. 4 indexed citations
14.
Tu, Luxia, Zhen Liu, Ying He, et al.. (2010). Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma. Molecular Cancer. 9(1). 78–78. 53 indexed citations
15.
Zhong, Xueyun, et al.. (2010). Expression and significance of tumor drug resistance related proteins and beta-catenin in esophageal squamous cell carcinoma. Chinese Journal of Cancer. 29(3). 300–305. 15 indexed citations
16.
Fang, Weiyi, Xin Li, Qingping Jiang, et al.. (2008). Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. Journal of Translational Medicine. 6(1). 32–32. 142 indexed citations
17.
Xie, Siming, et al.. (2006). [Expression of tumor suppressor gene PTEN, PIP3 and cyclin D1 in oral squamous cell carcinoma and their correlations].. PubMed. 41(7). 407–10. 2 indexed citations
18.
Xie, Siming, et al.. (2005). [Expressions of PTEN and FHIT in oral squamous cell carcinoma and their relations with cyclin D1].. PubMed. 25(1). 79–82. 1 indexed citations
19.
Xie, Siming, et al.. (2005). [Expression and significance of fragile histidine triad in oral cancer and precancerous lesions].. PubMed. 25(5). 584–6.
20.
Xie, Siming, et al.. (2005). [Expressions of FHIT and cyclin D1/CDK4 in oral cancer and oral precancerous lesions].. PubMed. 25(7). 812–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026